Announcement of change Spokesperson

Announcement of change of CEO

Announcement on behalf of Obigen that the BOD resolved to issue 2023 employee stock options and the subscription rules.

Announcement on behalf of Obigen to change its financial and accounting officer

The Company’s BOD resolved to amend the plan to disperse shareholding of Obigen (New Shareholding Dispersal Method)

The Company’s BOD resolved to amend the plan to disperse shareholding of AP Biosciences (New Shareholding Dispersal Method)

The Company’s Board of Directors resolved to issue 2023 employee stock options and the subscription rules.

The Company's Board of Directors resolved to convene the 2023 Annual General Shareholders' Meeting (New Approval)

Announcement of the Consolidated Financial Statements for the first quarter of 2023 were approved by the Board of Directors.

Announcement on behalf of Amaran of not Distributing Dividends of 2022